Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | checkpoint kinase 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | Protein kinase domain containing protein | Get druggable targets OG5_130454 | All targets in OG5_130454 |
Schistosoma mansoni | serine/threonine protein kinase | Get druggable targets OG5_130454 | All targets in OG5_130454 |
Loa Loa (eye worm) | CAMK/CAMKL/CHK1 protein kinase | Get druggable targets OG5_130454 | All targets in OG5_130454 |
Schistosoma japonicum | Serine/threonine-protein kinase Chk1, putative | Get druggable targets OG5_130454 | All targets in OG5_130454 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0999 | 0.1391 | 0.1943 |
Loa Loa (eye worm) | hypothetical protein | 0.0999 | 0.1391 | 0.1943 |
Echinococcus multilocularis | a disintegrin and metalloproteinase with | 0.3109 | 0.4612 | 0.465 |
Echinococcus multilocularis | adam | 0.0095 | 0.001 | 0.001 |
Echinococcus multilocularis | 0.0195 | 0.0162 | 0.0164 | |
Schistosoma mansoni | matrix metallopeptidase-9 (M10 family) | 0.0624 | 0.0818 | 0.0824 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0195 | 0.0162 | 0.5 |
Schistosoma mansoni | ADAM17 peptidase (M12 family) | 0.6585 | 0.9917 | 1 |
Brugia malayi | Matrixin family protein | 0.0999 | 0.1391 | 0.3 |
Loa Loa (eye worm) | CAMK/CAMKL/CHK1 protein kinase | 0.0202 | 0.0174 | 0.0018 |
Onchocerca volvulus | Matrilysin homolog | 0.2216 | 0.3249 | 1 |
Schistosoma mansoni | ADAMTS5 peptidase (M12 family) | 0.3109 | 0.4612 | 0.465 |
Brugia malayi | Hemopexin family protein | 0.1084 | 0.1521 | 0.3282 |
Brugia malayi | cytochrome P450 | 0.0195 | 0.0162 | 0.0331 |
Onchocerca volvulus | Matrilysin homolog | 0.0999 | 0.1391 | 0.3895 |
Leishmania major | lanosterol 14-alpha-demethylase, putative | 0.0195 | 0.0162 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0195 | 0.0162 | 0.0331 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.1217 | 0.1723 | 1 |
Onchocerca volvulus | 0.0999 | 0.1391 | 0.3895 | |
Echinococcus granulosus | adam | 0.0095 | 0.001 | 0.001 |
Onchocerca volvulus | 0.1084 | 0.1521 | 0.4321 | |
Mycobacterium ulcerans | hydrolase | 0.1217 | 0.1723 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0202 | 0.0174 | 0.0175 |
Leishmania major | cytochrome p450-like protein | 0.0195 | 0.0162 | 0.5 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.1217 | 0.1723 | 0.3723 |
Echinococcus granulosus | a disintegrin and metalloproteinase with | 0.3109 | 0.4612 | 0.4612 |
Brugia malayi | metalloprotease disintegrin 16 with thrombospondin type I motif | 0.3109 | 0.4612 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.4335 | 0.6483 | 1 |
Trypanosoma brucei | Lanosterol 14-alpha demethylase | 0.0195 | 0.0162 | 0.5 |
Echinococcus multilocularis | Blood coagulation inhibitor, Disintegrin | 0.353 | 0.5253 | 0.5297 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0195 | 0.0162 | 0.5 |
Leishmania major | cytochrome p450-like protein | 0.0195 | 0.0162 | 0.5 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.3301 | 0.4904 | 0.4904 |
Brugia malayi | Matrixin family protein | 0.0999 | 0.1391 | 0.3 |
Loa Loa (eye worm) | hypothetical protein | 0.1217 | 0.1723 | 0.2469 |
Schistosoma mansoni | hypothetical protein | 0.1084 | 0.1521 | 0.1533 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.3301 | 0.4904 | 0.4945 |
Schistosoma mansoni | cytochrome P450 | 0.0195 | 0.0162 | 0.0164 |
Loa Loa (eye worm) | hypothetical protein | 0.0999 | 0.1391 | 0.1943 |
Echinococcus multilocularis | adam 17 protease | 0.6585 | 0.9917 | 1 |
Toxoplasma gondii | cytochrome p450 superfamily protein | 0.0195 | 0.0162 | 0.5 |
Loa Loa (eye worm) | matrixin family protein | 0.2216 | 0.3249 | 0.4883 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0196 | 0.0164 | 0.0003 |
Trypanosoma brucei | cytochrome P450, putative | 0.0195 | 0.0162 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0195 | 0.0162 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0195 | 0.0162 | 0.0331 |
Loa Loa (eye worm) | matrix metalloproteinase | 0.0999 | 0.1391 | 0.1943 |
Leishmania major | cytochrome p450-like protein | 0.0195 | 0.0162 | 0.5 |
Trichomonas vaginalis | set domain proteins, putative | 0.0223 | 0.0205 | 0.5 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.0999 | 0.1391 | 0.1402 |
Schistosoma mansoni | adam (A disintegrin and metalloprotease | 0.0095 | 0.001 | 0.001 |
Trypanosoma cruzi | cytochrome p450-like protein, putative | 0.0195 | 0.0162 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0195 | 0.0162 | 0.0331 |
Schistosoma mansoni | hypothetical protein | 0.0195 | 0.0162 | 0.0164 |
Brugia malayi | Matrixin family protein | 0.2084 | 0.3046 | 0.6597 |
Echinococcus granulosus | Blood coagulation inhibitor Disintegrin | 0.353 | 0.5253 | 0.5253 |
Loa Loa (eye worm) | matrixin family protein | 0.2084 | 0.3046 | 0.4562 |
Echinococcus granulosus | cytochrome P450 2K1 | 0.0195 | 0.0162 | 0.0162 |
Brugia malayi | Pre-SET motif family protein | 0.0196 | 0.0164 | 0.0335 |
Brugia malayi | Matrixin family protein | 0.0999 | 0.1391 | 0.3 |
Brugia malayi | Matrixin family protein | 0.0999 | 0.1391 | 0.3 |
Brugia malayi | Cytochrome P450 family protein | 0.0195 | 0.0162 | 0.0331 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0195 | 0.0162 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0202 | 0.0174 | 0.0355 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.1217 | 0.1723 | 1 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.2216 | 0.3249 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.